Terug
42
Ook genoteerd als
AXFOF
OTC
Dagbereik
€ 27,24
€ 27,24
52-Weeksbereik
€ 25,22
€ 27,24
Volume
100
50D / 200D Gem.
€ 27,24
/
€ 27,05
Vorige Slotkoers
€ 27,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 2,5 | 10,4 |
| P/B | 0,8 | 1,2 |
| ROE % | 32,1 | 12,6 |
| Net Margin % | 2,6 | 5,3 |
| Rev Growth 5Y % | 11,4 | 5,5 |
| D/E | 2,1 | 0,6 |
Belangrijkste Punten
Revenue grew 11,40% annually over 5 years — strong growth
ROE of 32,13% indicates high profitability
Debt/Equity of 2,05 — high leverage
Generating 5,05B in free cash flow
P/E of 2,51 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 5,34%
Groei
Revenue Growth (5Y)
11,40%
Revenue (1Y)6,06%
Earnings (1Y)6,71%
FCF Growth (3Y)14,36%
Kwaliteit
Return on Equity
32,13%
ROIC11,69%
Net Margin2,62%
Op. Margin4,01%
Veiligheid
Debt / Equity
2,05
Current Ratio0,71
Interest Coverage6,17
Waardering
P/E Ratio
2,51
P/B Ratio0,78
EV/EBITDA5,66
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,06% | Revenue Growth (3Y) | 4,84% |
| Earnings Growth (1Y) | 6,71% | Earnings Growth (3Y) | -0,38% |
| Revenue Growth (5Y) | 11,40% | Earnings Growth (5Y) | 2,13% |
| Profitability | |||
| Revenue (TTM) | 89,15B | Net Income (TTM) | 2,34B |
| ROE | 32,13% | ROA | 6,34% |
| Gross Margin | 14,73% | Operating Margin | 4,01% |
| Net Margin | 2,62% | Free Cash Flow (TTM) | 5,05B |
| ROIC | 11,69% | FCF Growth (3Y) | 14,36% |
| Safety | |||
| Debt / Equity | 2,05 | Current Ratio | 0,71 |
| Interest Coverage | 6,17 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 2,51 | P/B Ratio | 0,78 |
| P/S Ratio | 0,07 | PEG Ratio | 3,46 |
| EV/EBITDA | 5,66 | Dividend Yield | 0,03% |
| Market Cap | 5,88B | Enterprise Value | 20,21B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 89,15B | 84,06B | 81,11B | 73,47B | 57,89B |
| Net Income | 2,34B | 2,19B | 2,36B | 2,36B | 2,15B |
| EPS (Diluted) | 10,79 | 10,11 | 10,87 | 11,03 | 10,16 |
| Gross Profit | 13,13B | 12,23B | 11,33B | 10,08B | 8,95B |
| Operating Income | 3,57B | 3,29B | 3,35B | 3,10B | 2,70B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36,91B | 35,43B | 30,02B | 28,62B | 23,73B |
| Total Liabilities | 29,08B | 28,04B | 22,83B | 21,72B | 18,56B |
| Shareholders' Equity | 7,51B | 7,05B | 6,88B | 6,61B | 4,95B |
| Total Debt | 15,40B | 15,30B | 9,76B | 9,25B | 8,00B |
| Cash & Equivalents | 1,08B | 735,00M | 688,00M | 559,00M | 734,00M |
| Current Assets | 9,89B | 8,81B | 8,85B | 8,46B | 7,51B |
| Current Liabilities | 13,92B | 13,17B | 13,72B | 12,74B | 12,06B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#217 of 658
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026